Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

BACKGROUND: Despite increased atherothrombotic risk in type 2 diabetes mellitus, (T2DM) the best preventative antithrombotic strategy remains undetermined. We defined the effects of three antiplatelet agents on functional readout and biomarker kinetics in platelet activation and coagulation in patie...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cardiovasc Diabetol
Main Authors: Parker, William A. E., Schulte, Christian, Barwari, Temo, Phoenix, Fladia, Pearson, Sam M., Mayr, Manuel, Grant, Peter J., Storey, Robert F., Ajjan, Ramzi A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945631/
https://ncbi.nlm.nih.gov/pubmed/31910903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0981-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki